Should women with a BRCA1/2 mutation aged 60 and older be offered intensified breast cancer screening? – A cost-effectiveness analysis.
Metadata
Show full item recordType
ArticleAuthor/s
Phi, Xuan-AnhGreuter, Marcel J. W.
Obdeijn, Inge-Marie
Oosterwijk, Jan C
Feenstra, Talitha L
Houssami, Nehmat
de Bock, Geertruida H.
Abstract
This study aimed to investigate the cost-effectiveness of intensified breast cancer (BC) screening for women with a BRCA1/2 mutation aged 60–74. Simulated strategies were: (0) annual mammography as reference, (1) alternating annual mammography and MRI for women with dense breasts only; (2) addition of annual MRI for women with dense breasts only; (3) addition of annual MRI for all women.This study aimed to investigate the cost-effectiveness of intensified breast cancer (BC) screening for women with a BRCA1/2 mutation aged 60–74. Simulated strategies were: (0) annual mammography as reference, (1) alternating annual mammography and MRI for women with dense breasts only; (2) addition of annual MRI for women with dense breasts only; (3) addition of annual MRI for all women.
See less
See less
Date
2019Source title
The BreastVolume
45Publisher
ElsevierLicence
Copyright All Rights ReservedFaculty/School
Faculty of Medicine and Health, Sydney School of Public HealthShare